Latest / Raleigh News Today | 2 Min News | The Daily News Now!
First RAS Drug for Pancreatic Cancer Approved | Raleigh News
Pancreatic cancer just got a major breakthrough: the FDA approved Rasonque daraxonrasib, the first daily pill targeting the RAS protein in advanced cases—nearly doubling survival from 6.7 to 13.2 months. Revolution Medicines, once a cash-rich research firm with no revenue, now has a game-changing drug thanks to fast-track approval and early patient access. Priced at nearly $40K per month, it’s expensive—but analysts predict $11B+ in annual sales. Despite the hype, stock barely moved as investors already priced in the win. Now comes the hard part: convincing insurers to cover it—and beating…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.